A citation-based method for searching scientific literature

Denis Horgan, Marleen Jansen, Lada Leyens, Jonathan A Lal, Ralf Sudbrak, Erica Hackenitz, Ulrike Bußhoff, Wolfgang Ballensiefen, Angela Brand. Public Health Genomics 2014
Times Cited: 40







List of co-cited articles
102 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Working towards personalization in medicine: main obstacles to reaching this vision from today's perspective.
Lada Leyens, Denis Horgan, Jonathan A Lal, Kirsten Steinhausen, Kapaettu Satyamoorthy, Angela Brand. Per Med 2014
7
71

Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Henry M Dunnenberger, Kristine R Crews, James M Hoffman, Kelly E Caudle, Ulrich Broeckel, Scott C Howard, Robert J Hunkler, Teri E Klein, William E Evans, Mary V Relling. Annu. Rev. Pharmacol. Toxicol. 2015
211
12

Implementation and utilization of genetic testing in personalized medicine.
Noura S Abul-Husn, Aniwaa Owusu Obeng, Saskia C Sanderson, Omri Gottesman, Stuart A Scott.  2014
42
10

The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
A R Shuldiner, M V Relling, J F Peterson, J K Hicks, R R Freimuth, W Sadee, N L Pereira, D M Roden, J A Johnson, T E Klein,[...]. Clin. Pharmacol. Ther. 2013
105
10

Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin. Pharmacol. Ther. 2012
222
10

Clinical application of pharmacogenetics.
B B Spear, M Heath-Chiozzi, J Huff. Trends Mol Med 2001
245
10

Health data cooperatives - citizen empowerment.
E Hafen, D Kossmann, A Brand. Methods Inf Med 2014
41
10


Evidence based medicine: what it is and what it isn't.
D L Sackett, W M Rosenberg, J A Gray, R B Haynes, W S Richardson. BMJ 1996
10

Is precision medicine the route to a healthy world?
Denis Horgan, Angelo Paradiso, Gordon McVie, Ian Banks, Tom Van der Wal, Angela Brand, Mark Lawler. Lancet 2015
12
33

Implementing genomic medicine in the clinic: the future is here.
Teri A Manolio, Rex L Chisholm, Brad Ozenberger, Dan M Roden, Marc S Williams, Richard Wilson, David Bick, Erwin P Bottinger, Murray H Brilliant, Charis Eng,[...]. Genet. Med. 2013
300
10

Personalised medicine: the cognitive side of patients.
Ilaria Cutica, Gordon Mc Vie, Gabriella Pravettoni. Eur. J. Intern. Med. 2014
23
13

Pharmacogenetics: from bench to byte--an update of guidelines.
J J Swen, M Nijenhuis, A de Boer, L Grandia, A H Maitland-van der Zee, H Mulder, G A P J M Rongen, R H N van Schaik, T Schalekamp, D J Touw,[...]. Clin. Pharmacol. Ther. 2011
490
7


Pharmacogenetics in Europe: barriers and opportunities.
D Gurwitz, E Zika, M M Hopkins, S Gaisser, D Ibarreta. Public Health Genomics 2009
35
8

Ask not what personalized medicine can do for you--ask what you can do for personalized medicine.
Isabelle Budin-Ljøsne, Jennifer R Harris. Public Health Genomics 2015
11
27

Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU).
Kristine Sørensen, Jürgen M Pelikan, Florian Röthlin, Kristin Ganahl, Zofia Slonska, Gerardine Doyle, James Fullam, Barbara Kondilis, Demosthenes Agrafiotis, Ellen Uiters,[...]. Eur J Public Health 2015
354
7

A tiered-layered-staged model for informed consent in personal genome testing.
Eline M Bunnik, A Cecile J W Janssens, Maartje H N Schermer. Eur. J. Hum. Genet. 2013
48
7


What is personalized medicine: sharpening a vague term based on a systematic literature review.
Sebastian Schleidgen, Corinna Klingler, Teresa Bertram, Wolf H Rogowski, Georg Marckmann. BMC Med Ethics 2013
79
7


Pharmacogenomic information in drug labels: European Medicines Agency perspective.
F Ehmann, L Caneva, K Prasad, M Paulmichl, M Maliepaard, A Llerena, M Ingelman-Sundberg, M Papaluca-Amati. Pharmacogenomics J. 2015
62
7

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine.
Shuji Ogino, Charles S Fuchs, Edward Giovannucci. Expert Rev. Mol. Diagn. 2012
96
7



European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine.
Sebastian Schee Genannt Halfmann, Nikolaos Evangelatos, Peter Schröder-Bäck, Angela Brand. Per Med 2017
5
60

Barriers for integrating personalized medicine into clinical practice: a qualitative analysis.
Mehdi Najafzadeh, Jennifer C Davis, Pamela Joshi, Carlo Marra. Am. J. Med. Genet. A 2013
15
20

The theory of reference values: an unfinished symphony.
Gerard Siest, Joseph Henny, Ralph Gräsbeck, Peter Wilding, Claude Petitclerc, Josep M Queraltó, Peter Hyltoft Petersen. Clin. Chem. Lab. Med. 2013
46
5

Whole genome sequencing as a diagnostic test: challenges and opportunities.
Caitlin C Chrystoja, Eleftherios P Diamandis. Clin. Chem. 2014
39
5

Awareness regarding clinical application of pharmacogenetics among Japanese pharmacists.
Taku Obara, Shinya Abe, Michihiro Satoh, Sergio Ramón Gutiérrez Ubeda, Shoko Yoshimachi, Teruaki Goto.  2015
6
33

Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
Minhaz Uddin Ahmed, Ishtiaq Saaem, Pae C Wu, April S Brown. Crit. Rev. Biotechnol. 2014
47
5

miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?
Emeline Goretti, Daniel R Wagner, Yvan Devaux. Trends Mol Med 2014
45
5

Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
F Ciardiello, D Arnold, P G Casali, A Cervantes, J-Y Douillard, A Eggermont, A Eniu, K McGregor, S Peters, M Piccart,[...]. Ann. Oncol. 2014
53
5

Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation.
James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am. J. Clin. Pathol. 2010
7
28

Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999.
Payman Shahabi, Gérard Siest, Bernard Herbeth, Ndeye Coumba Ndiaye, Sophie Visvikis-Siest. Clin. Chim. Acta 2012
9
22

Laboratory medicine: challenges and opportunities.
Xavier Bossuyt, Kurt Verweire, Norbert Blanckaert. Clin. Chem. 2007
43
5

Challenges and opportunities for medical directors in pathology and laboratory medicine: standardization, integration, and innovation.
Subhash C Arya, James S Hernandez, Jane C Dale, Kevin E Bennet, Prathibha Varkey. Am. J. Clin. Pathol. 2010
3
66

The highs and lows of tumor biomarkers: lost illusions.
Bohuslav Melichar. Clin. Chem. Lab. Med. 2015
3
66

Personalized (laboratory) medicine: a bridge to the future.
Mario Plebani, Giuseppe Lippi. Clin. Chem. Lab. Med. 2013
14
14


Inter-individual variation of inflammatory markers of cardiovascular risks and diseases.
Hind Berrahmoune, John Lamont, Peter Fitzgerald, Sophie Visvikis-Siest. Clin. Chem. Lab. Med. 2005
13
15

Biomedical research: increasing value, reducing waste.
Malcolm R Macleod, Susan Michie, Ian Roberts, Ulrich Dirnagl, Iain Chalmers, John P A Ioannidis, Rustam Al-Shahi Salman, An-Wen Chan, Paul Glasziou. Lancet 2014
364
5

Policies to aid the adoption of personalized medicine.
Charity Nofziger, Marisa Papaluca, Andre Terzic, Scott Waldman, Markus Paulmichl. Nat Rev Drug Discov 2014
5
40

Personalized medicine and the clinical laboratory.
João Renato Rebello Pinho, Roberta Sitnik, Cristóvão Luis Pitangueira Mangueira. Einstein (Sao Paulo) 2014
4
50

Omics and drug response.
Urs A Meyer, Ulrich M Zanger, Matthias Schwab. Annu. Rev. Pharmacol. Toxicol. 2013
77
5

Pharmacogenomics and individualized medicine: translating science into practice.
K R Crews, J K Hicks, C-H Pui, M V Relling, W E Evans. Clin. Pharmacol. Ther. 2012
121
5


Clinical pharmacogenetics implementation: approaches, successes, and challenges.
Kristin W Weitzel, Amanda R Elsey, Taimour Y Langaee, Benjamin Burkley, David R Nessl, Aniwaa Owusu Obeng, Benjamin J Staley, Hui-Jia Dong, Robert W Allan, J Felix Liu,[...]. Am J Med Genet C Semin Med Genet 2014
115
5

Meaningful use of pharmacogenetics.
M J Ratain, J A Johnson. Clin. Pharmacol. Ther. 2014
15
13

Pharmacogenomics knowledge for personalized medicine.
M Whirl-Carrillo, E M McDonagh, J M Hebert, L Gong, K Sangkuhl, C F Thorn, R B Altman, T E Klein. Clin. Pharmacol. Ther. 2012
678
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.